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S u m m a r y  
 
B a c k g r o u n d .  Allogeneic hematopoietic stem cell 
transplantation (allo-HSCT) is a method of treatment in a 
variety of diseases, which involves replacing the recipient's 
bone marrow by healthy donor stem cells. 
O b j e c t i v e .  The aim of the study was the analysis of 
immune reconstitution in children and adolescents after allo-
HSCT. 
P a t i e n t s  a n d  m e t h o d s .  We analyzed 
lymphocyte subpopulations in 67 children after allo-HSCT 
for hematological malignancies and non-malignant diseases. 
B-cells, T-cells, NK (natural killer cells) and CD4/CD8 ratio 
were assayed in peripheral blood by flow cytometry using a 
set of antibodies CD2/CD19, CD3/CD4/CD8, 
CD3/CD16CD56 labeled with different fluorescent dyes. The 
tests were performed at 1, 3, 6, 9, 12, 15, 18 and 24 months 
after the HSCT. 
 
R e s u l t s .  Normalization of the number of 
lymphocytes occurred rapidly in the population of NK cells; 
however, significant decrease in the proportion of NK cells 
was observed at 6 months after HSCT (p=0.028). The 
recovery of T cells occurred after 3 months for CD2 and after 
6 months for CD3 cells. Within the B-cell population, a 
significant delay of reconstitution was observed: CD19 cell 
percentage exceeded 5% (p<0.001) in the ninth month after 
HSCT, while it was above 10% afterwards. The 
normalization of CD4/CD8 ratio was very slow and delayed 
and did not achieve normal values within 24 months after 
allo-HSCT. 
C o n c l u s i o n s .  Reconstitution of the immune 
system in children after allo-HSCT is the fastest for NK cells. 
Normal values of T- and B-lymphocytes were reached after 6 
and 9 months, respectively. CD4/CD8 ratio is a parameter the 
normalization of which requires at least two years. 
 
 
S t r e s z c z e n i e  
 
W s t ę p .  Przeszczepienie allogenicznych komórek 
krwiotwórczych (allo-HSCT) to metoda terapeutyczna 
polegająca na zastąpieniu szpiku kostnego biorcy przez 
komórki hematopoetyczne pochodzące od zdrowego dawcy. 
C e l .  Analiza subpopulacji limfocytów u dzieci po 
przeszczepieniu allogenicznych komórek krwiotwórczych. 
P a c j e n c i  i  m e t o d y k a . Badaniu poddanych 
zostało 67 dzieci, u których przeprowadzono allo-HSCT  
z powodu chorób nowotworowych i nie-nowotworowych. 
We krwi obwodowej badano limfocyty B, T i NK oraz 
stosunek CD4/CD8 metodą cytometrii przepływowej, 
stosując zestawy przeciwciał CD2/CD19, CD3/CD4/CD8, 
CD3/CD16/CD56 wyznakowane różnymi barwnikami 
fluorescencyjnymi. Badania wykonano w 1, 3, 6, 9, 12, 15, 
18 i 24 miesiącu po HSCT. 
W y n i k i .  Normalizacja liczby limfocytów nastąpiła 
najszybciej w obrębie populacji komórek NK, jednak po  
6 miesiącach obserwowano znaczne zmniejszanie odsetka 
tych komórek (p=0,028). Normalizacja limfocytów T 
wystąpiła po 3 miesiącach dla CD2 i po 6 miesiącach dla 
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CD3. W obrębie limfocytów B stwierdzono istotne 
opóźnienie rekonstytucji: dopiero w 9 miesiącu odsetek 
komórek CD19+ przekroczył 5% (p<0,001), a w kolejnych 
punktach czasowych wynosił powyżej 10%. Rekonstytucja 
odsetka CD4/CD8 była powolna i opóźniona i nie osiągnęła 
normalizacji w przeciągu 24 miesięcy po allo-HSCT.  
W n i o s k i .  Rekonstytucja układu immunologicznego u 
dzieci po allo-HSCT najszybciej przebiega dla komórek NK. 
Prawidłowe wartości limfocytów T i B osiągane są 
odpowiednio, po około 6 i 9 miesiącach. Stosunek CD4/CD8 
jest parametrem, którego normalizacja wymaga co najmniej 2 
lat. 
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Hematopoietic stem cell transplantation (HSCT) is 
an established approach to treat patients with numerous 
hematological, oncological, immunological, metabolic 
and autoimmune disorders [1, 2]. The goal of 
hematopoietic stem cell transplantation is a transfer of 
a functional hematopoietic system from donor to host 
preceded by conditioning regimen with high-dose 
chemotherapy, sometimes in combination with total 
body irradiation [3, 4]. The clinical efficacy of HSCT 
is limited by delayed immune recovery resulting in 
high relapse rate and infectious complications [5]. A 
normal reconstitution of the immune system is an 
important issue for the control of infection, 
establishment of tolerance, and mediation of graft-
versus-leukemia (GVL) effects [6]. The reconstitution 
of different immune cell subsets after an HSCT occurs 
at different tempos [7]. Immune deficiencies, including 
cellular and antibody immunity can last for more than a 
year, resulting in increased susceptibility to infections 
[2]. Immune reconstitution after HSCT is influenced 
by many host-, donor- and transplantation-related 
factors [2]. 
 
PATIENTS AND METHODS 
 
Patients. A total number of 67 children, including 
45 males and 22 females, aged 8 months – 20 years 
(median 10 years) were included into the study. All 
patients underwent allogeneic HSCT for hematological 
malignancies (n=54) or non-malignant diseases (n=13). 
Patients were diagnosed for acute lymphoblastic 
leukemia (n=31), acute myeloid leukemia (n=19), 
chronic myeloid leukemia (n=1), myelodysplastic 
syndrome (n=1), lymphomas (n=2), or non-malignant 
diseases (n=13). HSCT were performed from matched 
family donor (n=25), matched unrelated donor (n=38), 
or mismatched unrelated donor (n=4). The stem cell 





Study design. Following lymphocyte 
subpopulations were tested: lymphocytes B, T, NK 
(natural killer) and CD4/CD8 ratio. Flow cytometry 
analysis was performed at 1, 3, 6, 9, 12, 15, 18 and 24 
months after HSCT. Not all children were examined at 
each time point. 
Flow cytometry analysis. The absolute numbers of 
B-, T-, NK and CD4/CD8 lymphocytes were calculated 
from a total number of PB lymphocytes, the proportion 
of side scatter/forward scatter lymphocyte region gate 
and the percentage of positive cells within the gate. 
The panel of monoclonal antibodies combinations used 
included: CD2/CD19 or CD5/CD19; CD3/CD4/CD8; 
CD3-/CD16CD56+. Antibodies were purchased from 
BD Bioscences (San Jose, CA, USA) and DAKO 
(Glostrup, Denmark). Briefly, 5µl of appropriate 
fluorochrome conjugated monoclonal antibodies were 
added to 50 µl of whole EDTA blood and vortexed. 
The samples were then incubated in the dark room 
temperature for 15 minutes. Erythrocyte lysis was 
performed with the use of Erythrocyte-Lysing Reagent 
Uti-Lyse DAKO (Glostrup, Denmark) after first 
incubation, 50µl of Erythrocyte-Lysing Reagent A was 
added to each sample, vortexed and incubated for 10 
minutes in dark. The same procedure was repeated 
with 500µl of Erythrocyte-Lysing Reagent B. 
Expression of all antigens was analyzed by flow 
cytometer FACSCanto II BD Bioscencies (San Jose, 
CA, USA) and data was analyzed using FACSDiva 
Software BD Bioscencies (San Jose, CA, USA).  
Reference values. Results of lymphocyte B, T and 
NK percentages and CD4/CD8 ratio were compared 
with the reference values [8]. Following values were 
regarded as normal: 12-24% for B-lymphocytes, 63.2-
77.8% for T-lymphocytes, 5.4-18.6% for NK cells, and 
1.18-2.65 for CD4/CD8 ratio. 
Statistical analysis. Median values and range were 
shown. Kruskal-Wallis and Mann-Whitney tests were 
used to compare differences between groups. A p-
value <0.05 was considered to be significant. 





Normalization of the number of lymphocytes 
occurred rapidly in the population of NK cells, which 
was observed from the first month after allo-HSCT 
(Figure 1). However, a significant decrease in the 
proportion of NK cells was observed from 17% after 
the first month to 2.8% at 24 months after HSCT 
(p=0.028). In the meantime, reconstitution of other 
lymphocyte subpopulations was observed. The 
normalization of T cells occurred after 3 months for 
CD2 and 6 months for CD3 cells. The percentages of T 
cells remained above 60% with no significant 
differences in the consecutive time points (p>0.05). A 
significant delay in reconstitution was found within the 
B cell population: CD19 cell percentage exceeded 5% 
in the 9th month after HSCT (p<0.001); while in the 
subsequent time points it was above 10%. A significant 
delay in reconstitution of CD3+CD4+ has also been 
observed (p<0.001), as late as after the 12th months 
their proportion exceeded only 20%. Normalization of 
the percentage of CD3+CD8+ cells appeared with CD2 
cell reconstitution in the third month after allo-HSCT. 
A steady increase of the percentage of CD3+CD8+ 
cells was observed in the following time points up to 
47% at 18 months after HSCT. As a result, 
reconstitution of CD4/CD8 ratio was slow and delayed 
(p=0.072) and did not achieve normal values within 24 




Allogeneic HSCT has proved to be an effective 
treatment in a variety of diseases. However, this 
procedure is associated with the risk of serious side 
effects, due to the severe impairment of the immune 
system induced by this 
treatment. Conditioning 
regimen with high-dose 
chemotherapy or total 
body irradiation is used to 
help eradicate the patient 
disease prior to the 
infusion of HSC; however, 
this therapy usually 
severely impairs immune 
system. First 100 days 
after HSCT are 
characterized by cellular 
immune deficiency with a 
reduced value of each 
subset of lymphocytes [7]. 
Immunocompromised 
patients after HSCT are 
more vulnerable to 
opportunistic and typical 
infections and have a 
higher risk of relapse. The 
reconstitution of the 
immune system is usually 
determined by white blood 
cell count with differential 





antibody levels.  
 
Fig. 1. Results of reconstitution of B (A), T (B), NK (C) lymphocytes and CD4/CD8 ratio (D) 
Ryc. 1. Poziom rekonstytucji limfocytów B (A), T (B), NK (C) i stosunku CD4/CD8 (D) 
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NK cells remains the first subset of lymphocytes to 
recover after autologous or allogeneic HSCT and 
possess the highest cytotoxic activity in early post-
transplant period [9]. Rapid recovery of NK cells after 
HSCT – in our study one month – is based on an 
expansion of the cytokine-producing CD56bright NK-
cell subset. This early expansion of CD56bright NK 
cells gradually declines; however, it may persist for a 
year [7]. Our study has shown that the number of NK 
cells significantly decreases over the time.  
The count of B-lymphocytes in our group of 
children and adolescents has returned to normal values 
at 6-9 months after allo-HSCT. Bosch et al. also 
observed intermediate recovery for B-cells, which was 
faster for naive than memory B-cells (CD5+ vs CD5- 
cells) [10]. Corre et al. reported expansion of 
CD19+/CD5+ lymphocytes just after three months and 
a persisting defect of memory B cells in adult patients 
[11]. According to Heining et al., CD19-positive B-
cells were normalized after a year in most adult 
patients [12]. 
Long-term imbalance between recovery of two 
major T-cell subsets, helper T-cells (CD3+CD4+) and 
suppressor/cytotoxic T-cell (CD3+CD8+) remains a 
well-known phenomenon [5]. Initial recovery of the T-
cell compartment relies on peripheral expansion of 
memory T cells, driven by cytokines and the presence 
of alloreactive antigens, before the production of naive 
T cells in the thymus starts. This is especially true for 
CD4+ T-cells that reconstitute later than CD8+ T-cells 
and rely more on thymic production of naive T cells 
after HSCT, leading to an inversion of the CD4/CD8 
ratio [7]. Our results confirm this hypothesis. Although 
the normalization of T cell occurred after 3 months for 
CD2 and 6 months for CD3, a significant delay in 
reconstitution of helper T-lymphocytes CD3+CD4+ 
was shown, which resulted in slow and delayed 
reconstitution of CD4/CD8 ratio over 24 months.  
In conclusion, on the basis of the assessment of 
lymphocytes subsets, we have shown that immune 
reconstitution in children and adolescents after allo-
HSCT has occurred at different rates. Although 
appropriate level of NK cells was achieved by one 
month after HSCT, the percentages of CD19+, CD3+, 
CD2+ lymphocytes and CD4/CD8 ratio indicated a 
delayed reconstitution. Allogeneic HSCT offers the 
opportunity for treatment of patients with malignant 
and non-malignant disorders; however, delayed 
immune reconstitution and disease relapse remain 
significant limitations for its application. 
Understanding the causes of hampered immune 
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